Genesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:SKH
- CUSIP: 83066R10
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
Frequently Asked Questions for Genesis Healthcare (NYSE:SKH)
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "SKH."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:SKH) posted its quarterly earnings results on Monday, November, 3rd. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.06. The firm had revenue of $208.60 million for the quarter, compared to the consensus estimate of $208.10 million. The firm's revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.06 EPS. View Genesis Healthcare's Earnings History.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy Genesis Healthcare stock?
Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Genesis Healthcare stock cost?
One share of Genesis Healthcare stock can currently be purchased for approximately $8.30.
Consensus Ratings for Genesis Healthcare (NYSE:SKH) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Genesis Healthcare (NYSE:SKH)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Genesis Healthcare (NYSE:SKH)Earnings History by Quarter for Genesis Healthcare (NYSE:SKH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/3/2014||Q314||$0.07||$0.13||$208.10 million||$208.60 million||View||Listen|
|8/11/2014||Q214||$0.06||$0.07||$209.15 million||$207.00 million||View||Listen|
|5/5/2014||Q114||$0.07||$0.06||$210.39 million||$207.30 million||View||Listen|
|2/11/2014||Q413||$0.10||$0.06||$215.35 million||$208.30 million||View||Listen|
|11/4/2013||Q313||$0.10||$0.06||$214.47 million||$212.40 million||View||N/A|
|8/5/2013||Q2 2013||$0.16||$0.09||$219.58 million||$213.70 million||View||N/A|
|5/6/2013||Q1 2013||$0.18||$0.10||$222.52 million||$218.90 million||View||N/A|
|2/11/2013||Q4 2012||$0.19||$0.16||$219.67 million||$219.20 million||View||N/A|
|11/5/2012||Q312||$0.20||$0.21||$218.92 million||$216.60 million||View||N/A|
Earnings Estimates for Genesis Healthcare (NYSE:SKH)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS
Dividend History for Genesis Healthcare (NYSE:SKH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Genesis Healthcare (NYSE:SKH)Insider Trades by Quarter for Genesis Healthcare (NYSE:SKH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/14/2013||Boyd Hendrickson||CEO||Sell||48,774||$5.02||$244,845.48|| |
|8/6/2013||Boyd W Hendrickson||CEO||Sell||4,983||$6.03||$30,047.49|| |
|8/5/2013||Boyd W Hendrickson||CEO||Sell||24,671||$6.49||$160,114.79|| |
|8/2/2013||Boyd W Hendrickson||CEO||Sell||45,346||$6.58||$298,376.68|| |
|7/2/2013||Boyd W Hendrickson||CEO||Sell||29,988||$6.46||$193,722.48|| |
|7/1/2013||Boyd W Hendrickson||CEO||Sell||28,112||$6.61||$185,820.32|| |
|11/1/2012||Boyd W Hendrickson||CEO||Sell||1,567||$8.00||$12,536.00|| |
Headline Trends for Genesis Healthcare (NYSE:SKH)
Latest Headlines for Genesis Healthcare (NYSE:SKH)
Genesis Healthcare (SKH) Chart for Wednesday, May, 24, 2017